- Home
- CVGW vs LRMR Comparison
CVGW vs LRMR Comparison
Compare CVGW & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVGW
- LRMR
- Stock Information
- Founded
- CVGW 1924
- LRMR N/A
- Country
- CVGW United States
- LRMR United States
- Employees
- CVGW N/A
- LRMR N/A
- Industry
- CVGW Specialty Foods
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- CVGW Consumer Discretionary
- LRMR Health Care
- Exchange
- CVGW Nasdaq
- LRMR Nasdaq
- Market Cap
- CVGW 453.6M
- LRMR 426.9M
- IPO Year
- CVGW N/A
- LRMR N/A
- Fundamental
- Price
- CVGW $24.69
- LRMR $3.34
- Analyst Decision
- CVGW Buy
- LRMR Strong Buy
- Analyst Count
- CVGW 2
- LRMR 8
- Target Price
- CVGW $33.50
- LRMR $19.63
- AVG Volume (30 Days)
- CVGW 226.9K
- LRMR 678.8K
- Earning Date
- CVGW 01-14-2025
- LRMR 03-13-2025
- Dividend Yield
- CVGW 3.24%
- LRMR N/A
- EPS Growth
- CVGW N/A
- LRMR N/A
- EPS
- CVGW N/A
- LRMR N/A
- Revenue
- CVGW $661,544,000.00
- LRMR N/A
- Revenue This Year
- CVGW N/A
- LRMR N/A
- Revenue Next Year
- CVGW $3.27
- LRMR N/A
- P/E Ratio
- CVGW $64.97
- LRMR N/A
- Revenue Growth
- CVGW 11.35
- LRMR N/A
- 52 Week Low
- CVGW $20.30
- LRMR $3.01
- 52 Week High
- CVGW $31.26
- LRMR $13.68
- Technical
- Relative Strength Index (RSI)
- CVGW 47.75
- LRMR 29.00
- Support Level
- CVGW $22.00
- LRMR $3.24
- Resistance Level
- CVGW $25.88
- LRMR $3.54
- Average True Range (ATR)
- CVGW 0.89
- LRMR 0.22
- MACD
- CVGW 0.03
- LRMR 0.03
- Stochastic Oscillator
- CVGW 69.33
- LRMR 12.26
About CVGW Calavo Growers Inc.
Calavo Growers Inc is in the avocado industry and an expanding provider of value-added fresh food. The company distributes its products both domestically and internationally and reports its operations in two different business segments: Grown and Prepared. The Grown segment consists of fresh avocados, tomatoes, and papayas. The Prepared segment comprises all other products including fresh-cut fruits and vegetables, ready-to-eat sandwiches, wraps, salads and snacks, guacamole, and salsa sold at retail and food service as well as avocado pulp sold to food service.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.